Masatoshi Takagaki Selected Research

Masatoshi Takagaki Research Topics

6	Stroke (Strokes) 01/2021 - 02/2014
2	Ischemic Stroke 01/2021 - 11/2020
2	Embolic Stroke 12/2019 - 01/2019
2	Lung Neoplasms (Lung Cancer) 04/2017 - 01/2016
2	Brain Neoplasms (Brain Tumor) 04/2017 - 01/2016
1	Aspergillosis 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	COVID-19 01/2022
1	Aneurysm (Aneurysms) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Cerebral Infarction 12/2019
1	Intracranial Embolism 01/2019
1	Neoplasm Metastasis (Metastasis) 04/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2017
1	Neoplasms (Cancer) 01/2016
1	Adenocarcinoma of Lung 01/2016
1	Infarction (Infarctions) 02/2014
1	Ischemia 02/2014
1	Wounds and Injuries (Trauma) 02/2014
1	Brain Injuries (Brain Injury) 02/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2014

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 04/2017 - 01/2016
1	Voriconazole (Vfend)FDA LinkGeneric 01/2023
1	Interferon Type IIBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	argatroban (MPQA)FDA Link 01/2020
1	AntibodiesIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	fibrin fragment D (D-dimer)IBA 07/2017
1	Tyrosine Kinase InhibitorsIBA 04/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2017
1	Indicators and Reagents (Reagents)IBA 07/2014
1	Isoflurane FDA LinkGeneric 02/2014
1	Propofol (Diprivan)FDA LinkGeneric 02/2014
1	Hypnotics and Sedatives (Sedatives)IBA 02/2014

3	Therapeutics 01/2023 - 12/2019
3	Thrombectomy 01/2021 - 12/2019
2	Heart-Assist Devices 11/2020 - 12/2019
1	Heart Transplantation (Grafting, Heart) 01/2020
1	Molecular Targeted Therapy 01/2016
1	Drug Therapy (Chemotherapy) 01/2016